Hims Hers

Based in the United States, Hims Hers is a startup founded in 2017. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Hims & Hers is a telehealth company offering prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer model, providing consultations with licensed healthcare professionals for a range of health concerns including sexual health, hair loss, weight loss, mental health, and dermatology.